NASDAQ : ONC
BeOne Medicines AG — Financial statements
Healthcare · Biotechnology · Switzerland
Last price 370.33 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 42.11B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BeOne Medicines AG (ONC) reported revenue of 6.13B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 6.04B | 5.28B | 3.78B | 2.19B | 1.42B | 1.18B |
| Other Revenue | 90.39M | 60.97M | 30.70M | 268.93M | ||
| Revenue | 6.13B | 5.34B | 3.81B | 2.46B | 1.42B | 1.18B |
| Cost of Revenue | 680.68M | 668.54M | 594.09M | 379.92M | 286.48M | 164.91M |
| Gross Profit | 5.45B | 4.67B | 3.22B | 2.08B | 1.13B | 1.01B |
| Selling, General & Admin | 2.23B | 2.08B | 1.83B | 1.51B | 1.28B | 990.12M |
| Research & Development | 2.29B | 2.15B | 1.95B | 1.78B | 1.64B | 1.46B |
| Amortization of Goodwill & Intangibles | 750.00K | |||||
| Operating Expenses | 4.53B | 4.23B | 3.78B | 3.29B | 2.92B | 2.45B |
| Operating Income | 923.10M | 447.14M | -568.20M | -1.21B | -1.79B | -1.44B |
| Interest Expense | -115.86M | -58.23M | -21.80M | -4.36M | -19.11M | -28.21M |
| Interest & Investment Income | 101.73M | 70.50M | 69.64M | 78.37M | 71.58M | 12.45M |
| Earnings From Equity Investments | -915.00K | -14.98M | -10.28M | -7.86M | -3.68M | -1.80M |
| Other Non Operating Income (Expenses) | 24.50M | 31.96M | 6.54M | -40.30M | -195.13M | 8.31M |
| EBT Excluding Unusual Items | 919.25M | 476.39M | -524.10M | -1.18B | -1.94B | -1.45B |
| Gain (Loss) on Sale of Investments | -51.17M | -59.53M | -8.90M | -6.87M | -25.04M | 9.39M |
| Other Unusual Items | 362.92M | |||||
| Pretax Income | 868.08M | 416.85M | -533.00M | -825.84M | -1.96B | -1.44B |
| Income Tax Expense | 212.37M | 129.92M | 111.78M | 55.87M | 42.78M | 19.23M |
| Earnings From Continuing Operations | 655.71M | 286.93M | -644.79M | -881.71M | -2.00B | -1.46B |
| Net Income | 655.71M | 286.93M | -644.79M | -881.71M | -2.00B | -1.46B |
| Net Income to Common | 655.71M | 286.93M | -644.79M | -881.71M | -2.00B | -1.46B |
| Shares Outstanding (Basic) | 110.88M | 109.06M | 105.29M | 104.39M | 103.13M | 92.79M |
| Shares Outstanding (Diluted) | 115.41M | 113.45M | 105.29M | 104.39M | 103.13M | 92.79M |
| EPS (Basic) | 5.91 | 2.63 | -6.12 | -8.45 | -19.43 | -15.71 |
| EPS (Diluted) | 5.59 | 2.47 | -6.12 | -8.45 | -19.43 | -15.71 |
| Free Cash Flow | 1.33B | 941.74M | -633.29M | -1.72B | -1.82B | -1.56B |
| Free Cash Flow Per Share | 11.53 | 8.30 | -6.01 | -16.47 | -17.67 | -16.83 |
| Gross Margin | 88.89% | 87.49% | 84.41% | 84.55% | 79.77% | 85.98% |
| Operating Margin | 15.06% | 8.37% | -14.91% | -49.12% | -126.40% | -122.31% |
| Profit Margin | 10.70% | 5.37% | -16.92% | -35.86% | -141.52% | -123.93% |
| Free Cash Flow Margin | 21.70% | 17.63% | -16.62% | -69.93% | -128.68% | -132.76% |
| EBITDA | 1.07B | 578.82M | -401.17M | -1.12B | -1.73B | -1.39B |
| EBITDA Margin | 17.48% | 10.83% | -10.53% | -45.71% | -121.94% | -118.44% |
| D&A For EBITDA | 148.51M | 131.68M | 167.03M | 83.94M | 63.05M | 45.49M |
| EBIT | 923.10M | 447.14M | -568.20M | -1.21B | -1.79B | -1.44B |
| EBIT Margin | 15.06% | 8.37% | -14.91% | -49.12% | -126.40% | -122.31% |
| Effective Tax Rate | 24.46% | 31.17% | ||||
| Revenue as Reported | 6.13B | 5.34B | 3.81B | 2.46B | 1.42B | 1.18B |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.10B | 4.55B | 2.63B | 3.17B | 3.87B | 4.38B |
| Short-Term Investments | 665.25M | 2.24B | ||||
| Cash & Short-Term Investments | 5.10B | 4.55B | 2.63B | 3.17B | 4.53B | 6.62B |
| Accounts Receivable | 1.06B | 865.08M | 676.28M | 358.03M | 173.17M | 483.11M |
| Other Receivables | 14.78M | 21.78M | 32.83M | 37.86M | 25.82M | 17.06M |
| Receivables | 1.07B | 886.86M | 709.11M | 395.89M | 198.98M | 500.18M |
| Inventory | 732.60M | 608.23M | 494.99M | 416.12M | 282.35M | 242.63M |
| Prepaid Expenses | 34.37M | 55.93M | 49.37M | 88.26M | 83.09M | 138.81M |
| Restricted Cash | 161.05M | 41.28M | 9.31M | 11.47M | 196.00K | 328.00K |
| Other Current Assets | 118.79M | 93.76M | 101.41M | 119.88M | 107.64M | 111.32M |
| Total Current Assets | 7.22B | 6.23B | 3.99B | 4.20B | 5.21B | 7.61B |
| Property, Plant & Equipment | 1.79B | 1.79B | 1.72B | 1.42B | 955.91M | 705.04M |
| Long-Term Investments | 66.06M | 61.68M | 128.93M | 89.64M | 91.78M | 100.79M |
| Goodwill | 109.00K | |||||
| Other Intangible Assets | 60.96M | 62.70M | 51.09M | 57.14M | 40.62M | 46.68M |
| Other Long-Term Assets | 43.52M | 40.74M | 31.56M | 35.72M | 83.91M | 69.03M |
| Total Assets | 9.18B | 8.19B | 5.92B | 5.81B | 6.38B | 8.54B |
| Accounts Payable | 470.30M | 479.04M | 405.00M | 315.11M | 294.78M | 262.40M |
| Accrued Expenses | 948.76M | 961.09M | 780.48M | 624.91M | 480.10M | 534.33M |
| Short-Term Debt | 130.13M | 9.06M | 816.95M | 659.78M | 314.83M | 424.74M |
| Current Portion of Long-Term Debt | 150.04M | 104.94M | 34.58M | 28.58M | 14.14M | 2.82M |
| Current Portion of Leases | 21.95M | 20.70M | 17.58M | 21.95M | 24.04M | 21.93M |
| Current Income Taxes Payable | 76.31M | 41.62M | 25.93M | 22.95M | 25.19M | 21.39M |
| Current Unearned Revenue | 213.86M | 187.41M | ||||
| Other Current Liabilities | 321.68M | 212.37M | 134.39M | 136.82M | 101.59M | 144.53M |
| Total Current Liabilities | 2.12B | 1.83B | 2.21B | 1.81B | 1.47B | 1.60B |
| Long-Term Debt | 1.70B | 1.81B | 166.48M | 197.62M | 209.15M | 202.11M |
| Long-Term Leases | 48.20M | 52.94M | 44.28M | 22.25M | 34.52M | 43.04M |
| Long-Term Unearned Revenue | 28.45M | 28.98M | 30.32M | 34.20M | 80.20M | 266.64M |
| Pension & Post-Retirement Benefits | 17.76M | 18.17M | 16.41M | 14.99M | 7.76M | 7.81M |
| Long-Term Deferred Tax Liabilities | 57.39M | 53.21M | 42.01M | 16.49M | 16.00M | 14.17M |
| Other Long-Term Liabilities | 31.43M | 33.10M | 74.29M | 172.27M | 179.78M | 269.63M |
| Total Liabilities | 4.00B | 3.83B | 2.59B | 2.27B | 2.00B | 2.40B |
| Common Stock | 147.00K | 144.00K | 138.00K | 135.00K | 135.00K | 133.00K |
| Additional Paid-In Capital | 13.05B | 12.76B | 12.09B | 11.60B | 11.54B | 11.19B |
| Retained Earnings | -7.86B | -8.32B | -8.61B | -7.96B | -7.08B | -5.08B |
| Comprehensive Income & Other | -25.37M | -78.18M | -148.99M | -99.45M | -77.42M | 17.95M |
| Total Common Equity | 5.17B | 4.36B | 3.33B | 3.54B | 4.38B | 6.13B |
| Shareholders' Equity | 5.17B | 4.36B | 3.33B | 3.54B | 4.38B | 6.13B |
| Total Liabilities & Equity | 9.18B | 8.19B | 5.92B | 5.81B | 6.38B | 8.54B |
| Total Debt | 2.05B | 2.00B | 1.08B | 930.18M | 596.67M | 694.64M |
| Net Cash (Debt) | 3.05B | 2.55B | 1.55B | 2.24B | 3.94B | 5.93B |
| Net Cash Per Share | 26.41 | 22.46 | 14.70 | 21.47 | 38.19 | 63.87 |
| Filing Date Shares Outstanding | 113.70M | 110.94M | 106.72M | 104.58M | 104.32M | 102.68M |
| Total Common Shares Outstanding | 113.02M | 110.85M | 106.72M | 104.58M | 104.32M | 102.68M |
| Working Capital | 5.10B | 4.40B | 1.78B | 2.39B | 3.74B | 6.01B |
| Book Value Per Share | 45.78 | 39.34 | 31.22 | 33.82 | 42.02 | 59.73 |
| Tangible Book Value | 5.11B | 4.30B | 3.28B | 3.48B | 4.34B | 6.09B |
| Tangible Book Value Per Share | 45.24 | 38.78 | 30.75 | 33.28 | 41.63 | 59.27 |
| Land | 71.43M | 71.43M | 65.48M | 65.48M | 65.48M | 65.48M |
| Buildings | 1.21B | 1.19B | 607.86M | 231.66M | 222.45M | 144.08M |
| Machinery | 617.88M | 583.24M | 485.14M | 392.20M | 334.59M | 237.79M |
| Construction In Progress | 152.67M | 127.16M | 654.02M | 740.62M | 293.63M | 186.84M |
| Leasehold Improvements | 79.53M | 76.57M | 64.68M | 60.12M | 53.79M | 50.29M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 655.71M | 286.93M | -644.79M | -881.71M | -2.00B | -1.46B |
| Depreciation & Amortization | 148.51M | 131.68M | 167.03M | 83.94M | 63.05M | 45.49M |
| Other Amortization | 6.42M | 10.00M | 4.73M | 3.74M | 3.23M | 965.00K |
| Asset Writedown & Restructuring Costs | -92.98M | -100.40M | -13.23M | -8.49M | -27.74M | -28.99M |
| Loss (Gain) From Sale of Investments | 76.22M | 76.22M | 24.02M | 16.22M | 22.00M | -7.63M |
| Stock-Based Compensation | 525.33M | 510.86M | 441.62M | 367.62M | 303.16M | 240.71M |
| Other Operating Activities | 20.67M | 21.39M | 37.15M | -368.23M | 11.11M | 26.89M |
| Change in Accounts Receivable | -284.46M | -164.95M | -329.44M | -188.31M | 304.11M | -423.02M |
| Change in Inventory | -218.33M | -93.17M | -91.50M | -140.95M | -56.69M | -153.33M |
| Change in Accounts Payable | 111.03M | 79.83M | 121.50M | 21.48M | -4.35M | 20.01M |
| Change in Unearned Revenue | 1.29M | 1.29M | 633.00K | -255.59M | -151.82M | 407.70M |
| Change in Other Net Operating Assets | 534.65M | 367.89M | 141.64M | 192.82M | 41.14M | 30.30M |
| Operating Cash Flow | 1.48B | 1.13B | -140.63M | -1.16B | -1.50B | -1.30B |
| Capital Expenditures | -153.87M | -185.84M | -492.66M | -561.90M | -325.43M | -262.94M |
| Sale (Purchase) of Intangibles | -21.21M | -80.69M | -36.47M | -34.37M | -143.66M | -51.91M |
| Investment in Securities | -4.32M | -8.39M | -16.35M | 658.34M | 1.55B | 955.51M |
| Other Investing Activities | -3.08M | -1.24M | -2.86M | -2.08M | -1.49M | |
| Investing Cash Flow | -182.47M | -276.15M | -548.35M | 60.00M | 1.08B | 640.66M |
| Short-Term Debt Issued | 233.68M | 868.27M | 661.53M | 313.77M | 406.45M | |
| Long-Term Debt Issued | 850.59M | 9.05M | 22.50M | 37.37M | 16.84M | |
| Total Debt Issued | 920.95M | 1.08B | 877.32M | 684.03M | 351.15M | 423.29M |
| Short-Term Debt Repaid | -1.04B | -704.22M | -309.58M | -417.08M | -321.75M | |
| Long-Term Debt Repaid | -35.68M | -28.03M | -13.69M | |||
| Total Debt Repaid | -812.57M | -1.08B | -732.25M | -323.27M | -417.08M | -321.75M |
| Net Debt Issued (Repaid) | 108.37M | 3.80M | 145.08M | 360.77M | -65.94M | 101.53M |
| Issuance of Common Stock | 134.70M | 196.28M | 45.37M | 55.71M | 46.96M | 3.54B |
| Repurchase of Common Stock | -24.20M | |||||
| Other Financing Activities | 877.71M | 883.56M | 3.00M | |||
| Financing Cash Flow | 1.12B | 1.06B | 193.45M | 416.48M | -18.97M | 3.64B |
| Foreign Exchange Rate Adjustments | 72.22M | 60.02M | -51.70M | -8.08M | -69.38M | 14.04M |
| Net Cash Flow | 2.49B | 1.97B | -547.24M | -689.05M | -507.85M | 2.99B |
| Free Cash Flow | 1.33B | 941.74M | -633.29M | -1.72B | -1.82B | -1.56B |
| Free Cash Flow Margin | 21.70% | 17.63% | -16.62% | -69.93% | -128.68% | -132.76% |
| Free Cash Flow Per Share | 11.53 | 8.30 | -6.01 | -16.47 | -17.67 | -16.83 |
| Levered Free Cash Flow | 879.02M | 655.53M | -370.91M | -1.27B | -943.69M | -1.20B |
| Unlevered Free Cash Flow | 951.44M | 691.93M | -357.28M | -1.27B | -931.75M | -1.19B |
| Cash Interest Paid | 54.75M | 52.45M | 51.17M | 19.75M | 25.17M | 29.97M |
| Cash Income Tax Paid | 91.51M | 100.68M | 69.43M | 56.00M | 29.50M | 15.70M |
| Change in Working Capital | 144.18M | 190.90M | -157.17M | -370.54M | 132.39M | -118.34M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 42.11B | 33.62B | 19.67B | 18.86B | 22.84B | 27.84B |
| Enterprise Value | 39.06B | 31.49B | 18.01B | 16.44B | 18.47B | 24.63B |
| Last Close Price | 370.33 | 303.81 | 184.71 | 180.36 | 219.94 | 270.93 |
| PE Ratio | 66.29 | 117.17 | ||||
| Forward PE | 45.99 | 66.95 | 76.37 | 76.37 | 76.37 | 76.37 |
| PS Ratio | 6.87 | 6.29 | 5.16 | 7.67 | 16.13 | 23.67 |
| PB Ratio | 8.09 | 7.71 | 5.90 | 5.33 | 5.21 | 4.54 |
| P/TBV Ratio | 8.24 | 7.82 | 5.99 | 5.42 | 5.26 | 4.58 |
| P/FCF Ratio | 31.66 | 35.70 | ||||
| P/OCF Ratio | 28.37 | 29.82 | ||||
| EV/Sales Ratio | 6.37 | 5.89 | 4.72 | 6.69 | 13.05 | 20.93 |
| EV/EBITDA Ratio | 36.45 | 54.40 | ||||
| EV/EBIT Ratio | 42.31 | 70.42 | ||||
| EV/FCF Ratio | 29.36 | 33.44 | ||||
| Debt / Equity Ratio | 0.40 | 0.46 | 0.32 | 0.26 | 0.14 | 0.11 |
| Debt / EBITDA Ratio | 1.86 | 3.28 | ||||
| Debt / FCF Ratio | 1.54 | 2.12 | ||||
| Net Debt / Equity Ratio | -0.59 | -0.58 | -0.46 | -0.63 | -0.90 | -0.97 |
| Net Debt / EBITDA Ratio | -2.85 | -4.40 | 3.86 | 2.00 | 2.28 | 4.25 |
| Net Debt / FCF Ratio | -2.29 | -2.71 | 2.44 | 1.30 | 2.16 | 3.79 |
| Asset Turnover | 0.79 | 0.76 | 0.65 | 0.40 | 0.19 | 0.17 |
| Inventory Turnover | 1.10 | 1.21 | 1.30 | 1.09 | 1.09 | 0.99 |
| Quick Ratio | 2.91 | 2.97 | 1.51 | 1.97 | 3.22 | 4.45 |
| Current Ratio | 3.40 | 3.41 | 1.80 | 2.32 | 3.55 | 4.76 |
| Return on Equity (ROE) | 14.66% | 7.46% | -18.77% | -22.26% | -38.11% | -29.15% |
| Return on Assets (ROA) | 7.46% | 3.96% | -6.06% | -12.39% | -15.00% | -12.72% |
| Return on Invested Capital (ROIC) | 33.62% | 17.11% | -36.89% | -138.75% | -401.98% | |
| Return on Capital Employed (ROCE) | 13.10% | 7.00% | -15.30% | -30.20% | -36.40% | -20.70% |
| Earnings Yield | 1.51% | 0.85% | -3.28% | -4.67% | -8.77% | -5.24% |
| FCF Yield | 3.16% | 2.80% | -3.22% | -9.12% | -7.98% | -5.61% |
| Buyback Yield / Dilution | -8.00% | -7.75% | -0.86% | -1.22% | -11.15% | -11.16% |